Ask My Investor AI
Public company · NYSEPublished company research
AME

Identity verified against SEC EDGAR filing 0001037868-26-000016; registered as AMETEK INC/, CIK 0001037868.

FARO exposure through AMETEK

FARO exposure through AMETEK is mapped to the Industrial inspection as the hidden reindustrialization bottleneck theme as 3D measurement: portable coordinate measuring arms, laser trackers and 3D laser scanners for dimensional inspection, now an AMETEK EMG business.. Medium via holding-company dilution: FARO is a direct, high-purity 3D metrology asset, but public exposure is only available through AMETEK, where the $920m acquisition (announced 6 May 2025, completed 21 Jul 2025) is small relative to AMETEK's $1.93bn quarterly sales. EMG (the receiving segment) grew 13% with +380bp margin in Q1 2026, consistent with — but not proof of — successful integration. Theme materiality is stated separately and, where not independently verified, is marked accordingly.

Ask follow-up research
Reviewed company research · researched 2026-07-22 · not an individual investment recommendation
Listing
public
Ticker
AME
Exchange
NYSE
HQ
—
Currency
USD
SEC CIK
0001037868
Investment case

How this company captures the theme economics

Competitive position

Medium via holding-company dilution: FARO is a direct, high-purity 3D metrology asset, but public exposure is only available through AMETEK, where the $920m acquisition (announced 6 May 2025, completed 21 Jul 2025) is small relative to AMETEK's $1.93bn quarterly sales. EMG (the receiving segment) grew 13% with +380bp margin in Q1 2026, consistent with — but not proof of — successful integration. Company-specific competitive positioning is assessed at the theme level and awaits deeper primary research.

Scarce assets

Scarce assets in this value chain include qualified ndt inspectors and certification auditors (shrinking certification pipeline vs growing demand; ~2-year advanced training cycles), regulatory accreditation and notified-body status for tic providers (multi-year, trust-based barrier), precision instrument manufacturing capacity and metrology-grade supply chains (optics, sensors, infrared detectors — teledyne reports 1.4x book-to-bill in digital imaging).

Products, segments, and customers

FARO exposure through AMETEK operates in Industrial inspection as the hidden reindustrialization bottleneck. Segment- and product-level detail is pending company-specific research.

Theme capture

Medium via holding-company dilution: FARO is a direct, high-purity 3D metrology asset, but public exposure is only available through AMETEK, where the $920m acquisition (announced 6 May 2025, completed 21 Jul 2025) is small relative to AMETEK's $1.93bn quarterly sales. EMG (the receiving segment) grew 13% with +380bp margin in Q1 2026, consistent with — but not proof of — successful integration.

Conditions

What must be true

  1. Search AMETEK's 10-K/10-Q purchase-price-allocation notes for FARO revenue and intangibles; watch for any AMETEK commentary quantifying metrology growth within EMG.
  2. The exposure described for FARO exposure through AMETEK must be confirmed as financially material in official filings.

Identifiable catalysts

  • Forthcoming quarterly and annual issuer filings
  • Theme-level catalysts detailed in the Industrial inspection as the hidden reindustrialization bottleneck brief
Theme materiality

1 mapped theme

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

3D measurement: portable coordinate measuring arms, laser trackers and 3D laser scanners for dimensional inspection, now an AMETEK EMG business.

Industrial inspection as the hidden reindustrialization bottleneck

Medium via holding-company dilution: FARO is a direct, high-purity 3D metrology asset, but public exposure is only available through AMETEK, where the $920m acquisition (announced 6 May 2025, completed 21 Jul 2025) is small relative to AMETEK's $1.93bn quarterly sales. EMG (the receiving segment) grew 13% with +380bp margin in Q1 2026, consistent with — but not proof of — successful integration.

Evidence
Acquisition dates and value confirmed via a fetched reference page (Wikipedia) and the role via deal description; AMETEK's fetched Q1 2026 release makes no FARO-specific disclosure, so post-close performance is unverified. This relationship is effectively a sub-thesis of rel-04 with lower standalone evidencing.
Materiality
estimated — The transaction ($920m) is disclosed, but FARO's revenue contribution and margin inside AMETEK are not separately disclosed in fetched materials; materiality to AMETEK is estimated as low-to-mid single-digit percent of sales based on deal size relative to group scale.
Financial evidence

Official SEC filing evidence

Reference period: FY2025.

  • Operating income$1.91 billion
    FY2025[1]
  • Diluted EPS$6.40
    FY2025[1]
  • Operating cash flow$1.80 billion
    FY2025[1]
  • Free cash flow$1.67 billion
    FY2025[1]
  • Cash and equivalents$458 million
    FY2025 year-end[1]

Limitation: Filing evidence establishes scale, profitability, cash generation, and leverage. Market-derived valuation is withheld until a licensed market-data feed is connected, and theme materiality is stated separately.

Risks

Material risks and break conditions

Material risks

  • Capex conversion failure: US construction spending was already down 1.5% YoY in May 2026; announced factories that are delayed or cancelled would remove the volume driver while equipment backlogs unwind.
  • Defense/nuclear concentration: much of the 2026 order strength (Teledyne, Curtiss-Wright) is defense- and nuclear-linked; a budget or program shock would hit the strongest current leg of the theme.

Thesis-break conditions

  • Manufacturing expansion cancelled: US private manufacturing/construction spending declining >5% YoY for two consecutive quarters, or multiple flagship fab/aircraft/nuclear programs formally cancelled.
  • Inspection commoditized: Cognex gross margin falling below ~60% and/or Keyence operating margin below ~45% for two consecutive years alongside falling average selling prices, indicating verification pricing power has broken.
Investability conclusion

Where the evidence lands

Identity and filing financials are established; theme materiality is stated per the mapped theme assessment. This is a filing-backed research profile with deeper company-specific research pending, and is not a personalized recommendation.

Next diligence

  1. Search AMETEK's 10-K/10-Q purchase-price-allocation notes for FARO revenue and intangibles; watch for any AMETEK commentary quantifying metrology growth within EMG.
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. AMETEK INC/ FY2025 Form 10-KSEC EDGAR · primary · published 2026-02-17 · accessed 2026-07-22